CYP19A1 and breast carcinoma: Furthermore, stable expressions of the clinically relevant HER-2 oncogene [14,15,16] or the gene for aromatase enzyme [17,18] have provided valuable models to examine the role of oncogenes and estrogens in breast cancer.